SIMPLMAB Trademark

Trademark Overview

On Tuesday, January 17, 2012, a trademark application was filed for SIMPLMAB with the United States Patent and Trademark Office. The USPTO has given the SIMPLMAB trademark a serial number of 79110271. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, January 17, 2022. This trademark is owned by INTERCELL AG. The SIMPLMAB trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Bio-pharmaceutical preparations containing monoclonal antibodies (MABs) for use in human and veterinary medicine, namely, for the treatment of cancers, infectious diseases and other chronic diseases, namely, Encephalitis, Hepatitis C, Tuberculosis, bladder cancer, travelers' diarrhea and Streptococci; vaccines; antibodies for use in human and veterinary medicine, namely, for the treatment of cancers, infectious diseases and other chronic diseases, namely, Encephalitis, Hepatitis C, Tuberculosis, bladder cancer, travelers' diarrhea and Streptococci; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; chemical preparations used in medical science, namely, for diagnosis, treatment and monitoring of cancer, infectious diseases and other chronic diseases, namely, Encephalitis, Hepatitis C, Tuberculosis, bladder cancer, travelers' diarrhea and Streptococci, all of the foregoing containing monoclonal antibodies

Development of medical test methods; chemical, medical, pharmaceutical and bacteriological research; laboratory services relating to the production of antibodies
simplmab

General Information

Serial Number79110271
Word MarkSIMPLMAB
Filing DateTuesday, January 17, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, January 17, 2022
Registration Number4355877
Registration DateTuesday, June 25, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2013

Trademark Statements

Goods and ServicesBio-pharmaceutical preparations containing monoclonal antibodies (MABs) for use in human and veterinary medicine, namely, for the treatment of cancers, infectious diseases and other chronic diseases, namely, Encephalitis, Hepatitis C, Tuberculosis, bladder cancer, travelers' diarrhea and Streptococci; vaccines; antibodies for use in human and veterinary medicine, namely, for the treatment of cancers, infectious diseases and other chronic diseases, namely, Encephalitis, Hepatitis C, Tuberculosis, bladder cancer, travelers' diarrhea and Streptococci; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; chemical preparations used in medical science, namely, for diagnosis, treatment and monitoring of cancer, infectious diseases and other chronic diseases, namely, Encephalitis, Hepatitis C, Tuberculosis, bladder cancer, travelers' diarrhea and Streptococci, all of the foregoing containing monoclonal antibodies
Goods and ServicesDevelopment of medical test methods; chemical, medical, pharmaceutical and bacteriological research; laboratory services relating to the production of antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 31, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 31, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameElatos GmbH
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressAT
Party NameINTERCELL AG
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressAT
Party NameINTERCELL AG
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressAT
Party NameINTERCELL AG
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressAT

Trademark Events

Event DateEvent Description
Monday, August 15, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, August 15, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, November 13, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, October 21, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, October 21, 2020INVALIDATION PROCESSED
Wednesday, September 30, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, January 31, 2020CANCELLED SECTION 71
Friday, May 24, 2019NEW REPRESENTATIVE AT IB RECEIVED
Friday, August 10, 2018NEW REPRESENTATIVE AT IB RECEIVED
Monday, June 25, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, January 11, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, December 20, 2013FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 20, 2013FINAL DISPOSITION PROCESSED
Wednesday, September 25, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, July 12, 2013CHANGE OF OWNER RECEIVED FROM IB
Tuesday, June 25, 2013REGISTERED-PRINCIPAL REGISTER
Sunday, June 2, 2013NOTIFICATION PROCESSED BY IB
Saturday, June 1, 2013NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, April 9, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 9, 2013PUBLISHED FOR OPPOSITION
Wednesday, March 20, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 20, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 20, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 4, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 27, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 27, 2013EXAMINER'S AMENDMENT ENTERED
Wednesday, February 27, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 27, 2013EXAMINERS AMENDMENT E-MAILED
Wednesday, February 27, 2013EXAMINERS AMENDMENT -WRITTEN
Thursday, February 14, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 14, 2013NON-FINAL ACTION E-MAILED
Thursday, February 14, 2013NON-FINAL ACTION WRITTEN
Friday, January 25, 2013PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, January 7, 2013WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, December 21, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 21, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 20, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 20, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 20, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 6, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 6, 2012NON-FINAL ACTION E-MAILED
Thursday, December 6, 2012NON-FINAL ACTION WRITTEN
Wednesday, November 21, 2012PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sunday, November 4, 2012WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, October 24, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 22, 2012ASSIGNED TO LIE
Tuesday, October 9, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 1, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 1, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 1, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 19, 2012REFUSAL PROCESSED BY IB
Monday, April 30, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, April 30, 2012REFUSAL PROCESSED BY MPU
Friday, April 27, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, April 26, 2012NON-FINAL ACTION WRITTEN
Tuesday, April 24, 2012ASSIGNED TO EXAMINER
Saturday, April 14, 2012APPLICATION FILING RECEIPT MAILED
Tuesday, April 10, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 9, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, April 6, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

simplmab namely diseases medical antibodies cancer encephalitis chronic chemical hepatitis streptococci